A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback